Thursday, September 07, 2023 11:47:27 AM
Recent PROF News
- Profound Medical’s Scheduled Presentation at the 43rd Annual J.P. Morgan Healthcare Conference Moved Up to 9:00am PT on January 16th • GlobeNewswire Inc. • 01/13/2025 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/08/2025 12:45:33 PM
- Profound Medical Announces Preliminary Unaudited Fourth Quarter and Full Year 2024 Revenues • GlobeNewswire Inc. • 01/08/2025 12:30:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 01/06/2025 01:30:07 PM
- Profound Medical to Present at the 43rd Annual J.P. Morgan Healthcare Conference • GlobeNewswire Inc. • 01/06/2025 01:15:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 12/16/2024 09:05:41 PM
- Profound Medical Announces Closing of US$40.25 Million Underwritten Public Offering of Common Shares • GlobeNewswire Inc. • 12/10/2024 02:55:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 12/06/2024 10:19:49 PM
- Form SUPPL - Voluntary Supplemental Material by Foreign Issuers [Section 11(a)] • Edgar (US Regulatory) • 12/06/2024 10:18:17 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 12/06/2024 08:10:55 PM
- Profound Medical Announces Pricing of US$35 Million Underwritten Public Offering of Common Shares • GlobeNewswire Inc. • 12/06/2024 02:04:58 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 12/05/2024 10:21:23 PM
- Form SUPPL - Voluntary Supplemental Material by Foreign Issuers [Section 11(a)] • Edgar (US Regulatory) • 12/05/2024 10:16:24 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 12/05/2024 10:01:35 PM
- Profound Medical Announces Proposed Public Offering of Common Shares • GlobeNewswire Inc. • 12/05/2024 09:48:14 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 12/02/2024 12:45:04 PM
- Profound Medical and Siemens Healthineers to Offer a Complete Solution for MRI-guided Prostate Therapy • GlobeNewswire Inc. • 12/02/2024 12:30:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 11/26/2024 01:00:17 PM
- Profound Medical to Unveil Next TULSA-AI® Module, ‘UA Alignment Assistant’ • GlobeNewswire Inc. • 11/26/2024 12:45:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 11/12/2024 06:52:50 PM
- Profound Medical to Participate in the Stifel 2024 Healthcare Conference • GlobeNewswire Inc. • 11/12/2024 01:00:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 11/07/2024 09:15:06 PM
- Profound Medical Announces Third Quarter 2024 Financial Results • GlobeNewswire Inc. • 11/07/2024 09:05:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 11/04/2024 12:15:04 PM
- Profound Medical Announces TULSA Reimbursement Raised to Urology APC Level 7 Under CMS Outpatient Prospective Payment System (OPPS) Final Rule for CY2025 • GlobeNewswire Inc. • 11/04/2024 11:55:00 AM
FEATURED Zefiro Methane Corp. Subsidiary Awarded Slate of Government of Ohio-Funded Environmental Remediation Projects • Jan 15, 2025 7:33 AM
FEATURED Mawson Finland Begins 2025 Drill Program, Mobilizing Multiple Drill Rigs at Rajapalot • Jan 15, 2025 7:18 AM
UAV Corp (OTC: UMAV) Engages Legal Counsel to Initiate Uplisting Process with Ultimate Goal of NASDAQ Listing • UMAV • Jan 15, 2025 8:30 AM
HealthLynked Welcomes Jeremy Daniel as Chief Financial Officer • HLYK • Jan 15, 2025 8:00 AM
GreetEat Corporation Announces Ticker Symbol Change to GEAT on OTC Markets • GEAT • Jan 14, 2025 9:40 AM
Unitronix Corp. Expands Stock Buyback Program, Reducing Outstanding Shares by Total of 165M • UTRX • Jan 14, 2025 8:14 AM